| ATM | Ataxia–telangiectasia mutated kinase |
| BLBCs | Basal-like breast cancer cells |
| β-TrCP | Beta-transducin repeat-containing protein |
| CBP | CREB-binding protein |
| CDK2 | Cyclin-dependent kinase 2 |
| CSN5 | COP9 signalosome subunit 5 |
| CtBP | C-terminal binding protein |
| CZF | C-terminal zinc finger |
| DUBs | Deubiquitinating enzymes |
| ECM | Extracellular matrix |
| EMT | Epithelial–mesenchymal transition |
| EMT-TFs | EMT-transcription factors |
| EndoMT | Endothelial-to-mesenchymal transition |
| ERK | Extracellular signal-regulated kinases |
| FBXL14 | F-Box and leucine-rich repeat protein 14 |
| FBXL5 | F-box and leucine-rich repeat protein 5 |
| FBXO11 | F-box only protein 11 |
| FBXO45 | F-box only protein 45 |
| FBXW7 | F-box/WD repeat-containing protein 7 |
| GSK3β | Glycogen synthase kinase 3 |
| HAT | Histone acetyltransferase |
| HCC | Hepatocellular carcinoma |
| HDAC1/2 | Histone deacetylase 1/2 |
| HNSCC | Head and neck squamous cell carcinoma |
| IGF-1 | Insulin-like growth factor-1 |
| IL-6 | Interleukin 6 |
| Lats2 | Large tumor suppressor kinase 2 |
| MAPK | Mitogen-activated protein kinase |
| MDM2 | Mouse double minute 2 homolog |
| MET | Mesenchymal–epithelial transition |
| MMPs | Matrix metalloproteinases |
| NF-κB | Nuclear factor-kappa B |
| NSCLC | Non-small cell lung cancer |
| NuRD | Nucleosome remodeling and deacetylation |
| NZF | N-terminal zinc finger |
| O-GlcNAc | O-linked β-N-acetylglucosamine |
| Pc2 | Polycomb protein 2 |
| PCAF | p300/CBP-associated factor |
| PI3K | Phosphoinositide 3-kinase |
| PKA | Protein kinase A |
| PKC | Protein kinase C |
| PKCα | Protein kinase C alpha |
| PKD1 | Protein kinase D1 |
| PRMTs | Protein arginine methyl transferases |
| PTM | Post-translational modification |
| SBD | SMAD-binding domain |
| SCP | Small C-terminal domain phosphatase |
| SRD | Serine-rich domain |
| TGF-β | Transforming growth factor beta |
| Tip60 | Tat-interacting protein of 60 kDa |
| USP51 | Ubiquitin specific peptidase 51 |
| ZnF | Zinc finger |